Pharmaceuticals Tuberculosis Diagnosis and Treatmen...

Tuberculosis Diagnosis and Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Type (Active TB, and Latent TB); Therapy (First-Line Therapy, and Second-Line Therapy); End Use (Clinics, Hospitals, Research Institutes and Academics, Reference Laboratories, and Others), and Geography

Report Code: TIPRE00022904 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Tuberculosis (TB) is a chronic disease and has become a global disease. Manufacturers of TB drugs are concerned with developing medications that can shorten the duration of treatment and help overcome the challenges of drug-susceptible TB and drug-resistant TB. TB treatment is divided into two types, such as first-line treatment, second-line treatment, and drug-resistant treatment. Advanced technologies and the introduction of novel therapies are expected to improve the duration of treating TB. However, most TB cases with currently available medicines can require up to 6 months of treatment. However, despite existing drugs and ongoing TB treatment drugs innovations, there is a continuous need to improve patients' access to appropriate TB medicines, particularly in the areas of multidrug-resistant TB (MDR TB) and pediatric TB.

MARKET SCOPE

The "Global Tuberculosis Diagnosis and Treatment Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the tuberculosis diagnosis and treatment market with detailed market segmentation by disease type, therapy, end use, and geography. The report provides key statistics on the market status of the leading tuberculosis diagnosis and treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on disease type, the global tuberculosis diagnosis and treatment market is segmented into active tb, latent tb.
  •  On the basis of therapy, the market is segmented into first-line therapy, second-line therapy.
  •  On the basis of end use, the market is segmented into clinics, hospitals, research institutes and academics, reference laboratories, others.

MARKET DYNAMICS
Drivers

  •  Rise in the incidences of drug susceptible tuberculosis.
  •  Advancements in testing kits technology.
  •  Increase research and development towards drug developments

Restraints

  •  The Second line treatment drugs are highly priced compared to first line treatment with more side effects and high level toxicity is the major restraining factor for this market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The tuberculosis diagnosis and treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the tuberculosis diagnosis and treatment market in these regions.

IMPACT OF COVID-19 ON TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS

The report covers key developments in the tuberculosis diagnosis and treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from tuberculosis diagnosis and treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for tuberculosis diagnosis and treatment in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the tuberculosis diagnosis and treatment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Medtronic
  •  St. Jude Medical (Abbott)
  •  Boston Scientific
  •  Cochlear
  •  Biotronik
  •  Sorin
  •  Abiomed
  •  MED-EL
  •  Nevro
  •  Sonova

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Tuberculosis Diagnosis And Treatment Market - By Disease Type
1.3.2 Tuberculosis Diagnosis And Treatment Market - By Therapy
1.3.3 Tuberculosis Diagnosis And Treatment Market - By End Use
1.3.4 Tuberculosis Diagnosis And Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. TUBERCULOSIS DIAGNOSIS AND TREATMENT - GLOBAL MARKET OVERVIEW
6.2. TUBERCULOSIS DIAGNOSIS AND TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE TYPE
7.1. OVERVIEW
7.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
7.3. ACTIVE TB
7.3.1. Overview
7.3.2. Active TB Market Forecast and Analysis
7.4. LATENT TB
7.4.1. Overview
7.4.2. Latent TB Market Forecast and Analysis
8. TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - THERAPY
8.1. OVERVIEW
8.2. THERAPY MARKET FORECASTS AND ANALYSIS
8.3. FIRST-LINE THERAPY
8.3.1. Overview
8.3.2. First-Line Therapy Market Forecast and Analysis
8.4. SECOND-LINE THERAPY
8.4.1. Overview
8.4.2. Second-Line Therapy Market Forecast and Analysis
9. TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - END USE
9.1. OVERVIEW
9.2. END USE MARKET FORECASTS AND ANALYSIS
9.3. CLINICS
9.3.1. Overview
9.3.2. Clinics Market Forecast and Analysis
9.4. HOSPITALS
9.4.1. Overview
9.4.2. Hospitals Market Forecast and Analysis
9.5. RESEARCH INSTITUTES AND ACADEMICS
9.5.1. Overview
9.5.2. Research Institutes and Academics Market Forecast and Analysis
9.6. REFERENCE LABORATORIES
9.6.1. Overview
9.6.2. Reference Laboratories Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Tuberculosis Diagnosis And Treatment Market Overview
10.1.2 North America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis
10.1.3 North America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Disease Type
10.1.4 North America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Therapy
10.1.5 North America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By End Use
10.1.6 North America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Tuberculosis Diagnosis And Treatment Market
10.1.6.1.1 United States Tuberculosis Diagnosis And Treatment Market by Disease Type
10.1.6.1.2 United States Tuberculosis Diagnosis And Treatment Market by Therapy
10.1.6.1.3 United States Tuberculosis Diagnosis And Treatment Market by End Use
10.1.6.2 Canada Tuberculosis Diagnosis And Treatment Market
10.1.6.2.1 Canada Tuberculosis Diagnosis And Treatment Market by Disease Type
10.1.6.2.2 Canada Tuberculosis Diagnosis And Treatment Market by Therapy
10.1.6.2.3 Canada Tuberculosis Diagnosis And Treatment Market by End Use
10.1.6.3 Mexico Tuberculosis Diagnosis And Treatment Market
10.1.6.3.1 Mexico Tuberculosis Diagnosis And Treatment Market by Disease Type
10.1.6.3.2 Mexico Tuberculosis Diagnosis And Treatment Market by Therapy
10.1.6.3.3 Mexico Tuberculosis Diagnosis And Treatment Market by End Use
10.2. EUROPE
10.2.1 Europe Tuberculosis Diagnosis And Treatment Market Overview
10.2.2 Europe Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis
10.2.3 Europe Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Disease Type
10.2.4 Europe Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Therapy
10.2.5 Europe Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By End Use
10.2.6 Europe Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Tuberculosis Diagnosis And Treatment Market
10.2.6.1.1 Germany Tuberculosis Diagnosis And Treatment Market by Disease Type
10.2.6.1.2 Germany Tuberculosis Diagnosis And Treatment Market by Therapy
10.2.6.1.3 Germany Tuberculosis Diagnosis And Treatment Market by End Use
10.2.6.2 France Tuberculosis Diagnosis And Treatment Market
10.2.6.2.1 France Tuberculosis Diagnosis And Treatment Market by Disease Type
10.2.6.2.2 France Tuberculosis Diagnosis And Treatment Market by Therapy
10.2.6.2.3 France Tuberculosis Diagnosis And Treatment Market by End Use
10.2.6.3 Italy Tuberculosis Diagnosis And Treatment Market
10.2.6.3.1 Italy Tuberculosis Diagnosis And Treatment Market by Disease Type
10.2.6.3.2 Italy Tuberculosis Diagnosis And Treatment Market by Therapy
10.2.6.3.3 Italy Tuberculosis Diagnosis And Treatment Market by End Use
10.2.6.4 Spain Tuberculosis Diagnosis And Treatment Market
10.2.6.4.1 Spain Tuberculosis Diagnosis And Treatment Market by Disease Type
10.2.6.4.2 Spain Tuberculosis Diagnosis And Treatment Market by Therapy
10.2.6.4.3 Spain Tuberculosis Diagnosis And Treatment Market by End Use
10.2.6.5 United Kingdom Tuberculosis Diagnosis And Treatment Market
10.2.6.5.1 United Kingdom Tuberculosis Diagnosis And Treatment Market by Disease Type
10.2.6.5.2 United Kingdom Tuberculosis Diagnosis And Treatment Market by Therapy
10.2.6.5.3 United Kingdom Tuberculosis Diagnosis And Treatment Market by End Use
10.2.6.6 Rest of Europe Tuberculosis Diagnosis And Treatment Market
10.2.6.6.1 Rest of Europe Tuberculosis Diagnosis And Treatment Market by Disease Type
10.2.6.6.2 Rest of Europe Tuberculosis Diagnosis And Treatment Market by Therapy
10.2.6.6.3 Rest of Europe Tuberculosis Diagnosis And Treatment Market by End Use
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Tuberculosis Diagnosis And Treatment Market Overview
10.3.2 Asia-Pacific Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Disease Type
10.3.4 Asia-Pacific Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Therapy
10.3.5 Asia-Pacific Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By End Use
10.3.6 Asia-Pacific Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Tuberculosis Diagnosis And Treatment Market
10.3.6.1.1 Australia Tuberculosis Diagnosis And Treatment Market by Disease Type
10.3.6.1.2 Australia Tuberculosis Diagnosis And Treatment Market by Therapy
10.3.6.1.3 Australia Tuberculosis Diagnosis And Treatment Market by End Use
10.3.6.2 China Tuberculosis Diagnosis And Treatment Market
10.3.6.2.1 China Tuberculosis Diagnosis And Treatment Market by Disease Type
10.3.6.2.2 China Tuberculosis Diagnosis And Treatment Market by Therapy
10.3.6.2.3 China Tuberculosis Diagnosis And Treatment Market by End Use
10.3.6.3 India Tuberculosis Diagnosis And Treatment Market
10.3.6.3.1 India Tuberculosis Diagnosis And Treatment Market by Disease Type
10.3.6.3.2 India Tuberculosis Diagnosis And Treatment Market by Therapy
10.3.6.3.3 India Tuberculosis Diagnosis And Treatment Market by End Use
10.3.6.4 Japan Tuberculosis Diagnosis And Treatment Market
10.3.6.4.1 Japan Tuberculosis Diagnosis And Treatment Market by Disease Type
10.3.6.4.2 Japan Tuberculosis Diagnosis And Treatment Market by Therapy
10.3.6.4.3 Japan Tuberculosis Diagnosis And Treatment Market by End Use
10.3.6.5 South Korea Tuberculosis Diagnosis And Treatment Market
10.3.6.5.1 South Korea Tuberculosis Diagnosis And Treatment Market by Disease Type
10.3.6.5.2 South Korea Tuberculosis Diagnosis And Treatment Market by Therapy
10.3.6.5.3 South Korea Tuberculosis Diagnosis And Treatment Market by End Use
10.3.6.6 Rest of Asia-Pacific Tuberculosis Diagnosis And Treatment Market
10.3.6.6.1 Rest of Asia-Pacific Tuberculosis Diagnosis And Treatment Market by Disease Type
10.3.6.6.2 Rest of Asia-Pacific Tuberculosis Diagnosis And Treatment Market by Therapy
10.3.6.6.3 Rest of Asia-Pacific Tuberculosis Diagnosis And Treatment Market by End Use
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Tuberculosis Diagnosis And Treatment Market Overview
10.4.2 Middle East and Africa Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Disease Type
10.4.4 Middle East and Africa Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Therapy
10.4.5 Middle East and Africa Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By End Use
10.4.6 Middle East and Africa Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Tuberculosis Diagnosis And Treatment Market
10.4.6.1.1 South Africa Tuberculosis Diagnosis And Treatment Market by Disease Type
10.4.6.1.2 South Africa Tuberculosis Diagnosis And Treatment Market by Therapy
10.4.6.1.3 South Africa Tuberculosis Diagnosis And Treatment Market by End Use
10.4.6.2 Saudi Arabia Tuberculosis Diagnosis And Treatment Market
10.4.6.2.1 Saudi Arabia Tuberculosis Diagnosis And Treatment Market by Disease Type
10.4.6.2.2 Saudi Arabia Tuberculosis Diagnosis And Treatment Market by Therapy
10.4.6.2.3 Saudi Arabia Tuberculosis Diagnosis And Treatment Market by End Use
10.4.6.3 U.A.E Tuberculosis Diagnosis And Treatment Market
10.4.6.3.1 U.A.E Tuberculosis Diagnosis And Treatment Market by Disease Type
10.4.6.3.2 U.A.E Tuberculosis Diagnosis And Treatment Market by Therapy
10.4.6.3.3 U.A.E Tuberculosis Diagnosis And Treatment Market by End Use
10.4.6.4 Rest of Middle East and Africa Tuberculosis Diagnosis And Treatment Market
10.4.6.4.1 Rest of Middle East and Africa Tuberculosis Diagnosis And Treatment Market by Disease Type
10.4.6.4.2 Rest of Middle East and Africa Tuberculosis Diagnosis And Treatment Market by Therapy
10.4.6.4.3 Rest of Middle East and Africa Tuberculosis Diagnosis And Treatment Market by End Use
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Tuberculosis Diagnosis And Treatment Market Overview
10.5.2 South and Central America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis
10.5.3 South and Central America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Disease Type
10.5.4 South and Central America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Therapy
10.5.5 South and Central America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By End Use
10.5.6 South and Central America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Tuberculosis Diagnosis And Treatment Market
10.5.6.1.1 Brazil Tuberculosis Diagnosis And Treatment Market by Disease Type
10.5.6.1.2 Brazil Tuberculosis Diagnosis And Treatment Market by Therapy
10.5.6.1.3 Brazil Tuberculosis Diagnosis And Treatment Market by End Use
10.5.6.2 Argentina Tuberculosis Diagnosis And Treatment Market
10.5.6.2.1 Argentina Tuberculosis Diagnosis And Treatment Market by Disease Type
10.5.6.2.2 Argentina Tuberculosis Diagnosis And Treatment Market by Therapy
10.5.6.2.3 Argentina Tuberculosis Diagnosis And Treatment Market by End Use
10.5.6.3 Rest of South and Central America Tuberculosis Diagnosis And Treatment Market
10.5.6.3.1 Rest of South and Central America Tuberculosis Diagnosis And Treatment Market by Disease Type
10.5.6.3.2 Rest of South and Central America Tuberculosis Diagnosis And Treatment Market by Therapy
10.5.6.3.3 Rest of South and Central America Tuberculosis Diagnosis And Treatment Market by End Use
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET, KEY COMPANY PROFILES
13.1. ABBOTT LABORATORIES INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AKONNI BIOSYSTEMS, INC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ALERE, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BECTON DICKINSON AND CO.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BIOCHEMICAL AND SYNTHETIC PRODUCTS PVT LTD
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. BIOMéRIEUX SA
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. CEPHEID INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. EIKEN CHEMICAL CO. LTD.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. EPISTEMLTD.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. F. HOFFMANN-LA ROCHE AG
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS


* Above given report scope is tentative, and may change during the study process as per the research requirement.
* List of companies provided under ‘Company Profile’ chapter is tentative and may change during the course of the study. This list is customizable as per the client requirements.
* Financial information would be provided only for the public comp
The List of Companies

1. Abbott Laboratories Inc.
2. Akonni Biosystems, Inc.
3. Alere, Inc.
4. Becton Dickinson and Co.
5. Biochemical and Synthetic Products Pvt Ltd
6. Biomérieux SA
7. Cepheid Inc.
8. Eiken Chemical Co. Ltd.
9. EpistemLtd.
10. F. Hoffmann-LA Roche AG
11. GlaxoSmithKline PLC
12. Hain Lifescience GmbH
13. HologicInc.
14. Johnson & Johnson Services, Inc.
15. LabatecPharma SA
16. Lupin Pharmaceuticals Inc.
17. Novartis AG
18. Otsuka Pharmaceutical Co. Ltd.
19. PerkinElmer Inc.
20. Lupin Pharmaceuticals Inc
TIPRE00022904
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Contact Us : +1-646-491-9876 | +91-20-67271633 | Email : sales@theinsightpartners.com
© Copyright 2021 - The Insight Partners. All rights reserved